Skip to content
Tuesday, November 10, 2026
HyperGambleHub

Individuals Stopping Slimming Medications Put On Weight Four Times Faster Compared to People Using Diet and Exercise

Image of medical syringe and scale
Obesity treatment involves ongoing approaches.

A recent study suggests that individuals who come off popular slimming jabs like Mounjaro or Wegovy can put back on reduced body mass at a significantly accelerated pace than those who end conventional diet and exercise programs.

Published data in a major medical journal points out that while obese people frequently drop a large proportion of their total mass while using the jabs, the mass returns at an estimated rate of nearly a kilo each month upon discontinuation.

"Individuals buying these drugs should be informed of the danger of rapid rebound weight gain when the medication concludes," warns lead investigator Dr. Susan Jebb.

This pace of recovery implies a reversion to starting mass within about 18 months.

Analyzing Treatments

The study, which reviewed 37 of studies involving thousands of participants, contrasted the outcomes of the injectable medications with other pills.

Scientists note that individuals who shed pounds through diet and exercise generally experience a slower creep back—around 0.1 kg a month—once they finish.

Understanding the Rapid Rebound

Doctors propose the way of the injections accounts for the accelerated rebound.

GLP-1 drugs copy a body's own chemical called GLP-1, which helps regulate appetite.

"Artificially providing the hormone levels several times higher than normal might result in the body to produce less of its endogenous hormone, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this medication leads to appetite is unsuppressed, making binge eating much more probable."

A Chronic Condition?

The NHS recommend the jabs for people with obesity-related health risks, alongside recommended diet and exercise modifications.

A number of clinicians argue that, due to the significant potential of relapse, the treatment is often ongoing.

This view is reinforced by drug manufacturers, who say that the results "highlight the chronic character of obesity," comparing it to managing conditions like high blood pressure.

User Experiences

People who have come off the medication explain a powerful resurgence of hunger.

"It was like a switch activating and I was suddenly extremely hungry," described one woman.

The struggle is worsened if patients have not established permanent dietary or behavioural changes during treatment.

Widespread Interest

Survey data show that a significant number of people in the UK have tried these injections in the last 12 months, with interest being substantial.

  • Adoption is more common among females than men.
  • The 40s and 50s age group shows the highest usage rates.
  • Many access the medications through private healthcare rather than public health services.

In conclusion, clinicians caution that while these medications are potent tools for weight loss, they are not a standalone cure and lasting health benefits relies on ongoing lifestyle support.

DW
Written by

David Wheeler

A seasoned gambling analyst with over a decade of experience in casino reviews and strategy development, specializing in online gaming trends.

HyperGambleHub

Type to search articles.